氧驱动雾化吸入布地奈德治疗小儿麻疹合并支气管肺炎的疗效观察

Efficacy of oxygen atomizing inhalation of budesonide in the treatment of pedo-measles complicated with bronchopneumonia patients

目的观察布地奈德通过氧驱动雾化吸入治疗小儿麻疹合并支气管肺炎的临床疗效。方法将90例麻疹合并支气管肺炎患儿随机分为治疗组48例、对照组42例,两组除常规给予抗感染、对症支持治疗外,治疗组给予氧驱动雾化吸入布地奈德混悬液。观察两组患儿咳嗽气促缓解时间、肺部啰音消失时间、呼吸困难改善时间、胸片吸收时间。观察治疗组患儿雾化吸入前后呼吸、心率及血氧饱和度,并观察两组疗效。结果两组患者咳嗽气促缓解时间、肺部啰音消失时间、呼吸困难改善时间、胸片吸收时间比较差异有统计学意义(P<0.05);治疗组患儿雾化吸入前后呼吸、心率及血氧饱和度比较差异有统计学意义(P<0.05);两组患儿临床疗效间比较有差异。结论在麻疹合并肺炎的患儿中通过氧驱动雾化吸入布地奈德混悬液,能有效改善患儿症状和体征,缩短病程。

Objective To observe the effect of oxygen atomizing inhalation of budesonide suspension, in the treatment of pedo-measles complicated with bronchopneumonia patients. Methods Ninety pedo-measles complicated with bronchopneumonia patients were selected and then randomly divided into two groups：treated group（48 cases） and the control group（42 cases）. The two groups patients were all treated with antibiotics and given support therapy. On this base, the treatment group were received oxygen atomizing inhalation of budesonide suspension. The remission time of cough and dyspnea, the disappearance time of lung rale, the improvement time of dyspnoea, the absorption time of chest radiograph, were observed in the two groups. Respiration, heart rate, the blood oxygen saturation were observed in the treated group before and after atomizing inhalation, the Efficacy were observed in the two groups. Re- suits The remission time of cough and dyspnea, the disapperance time of lung rale, the improvement time of dysp- noea,the absorption time of chest radiograph were significantly different between the two groups. Respiration, heart rate,the blood oxygen saturation were significantly different before and after atomizing inhalation in the treated group, the Efficacy were significantly different between the two groups. Conclusion The symptoms and signs are markedly improved in pedo-measles complicated with bronchopneumonia patients by oxygen atomizing inhalation of budesonide suspension. This therapy can shorten the course of the disease.